Merck & Company Inc (MRK) Insider Trading
- $75,946,918.00
- $707,254,046.89
- Sept. 4, 2024
- Kenneth C Frazier
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| March 5, 2019 | Chairman | 20,105 | $82.00 | Sell | $1,648,610.00 | |
| Feb. 22, 2019 | CEO | 53,961 | $80.02 | Sell | $4,317,959.22 | |
| Feb. 19, 2019 | Chairman | 135,613 | $80.03 | Sell | $10,853,108.39 | |
| Feb. 15, 2019 | CEO | 92,913 | $80.03 | Sell | $7,435,827.39 | |
| Feb. 14, 2019 | VP | 64,662 | $78.96 | Sell | $5,105,711.52 | |
| Feb. 13, 2019 | Director | 5,000 | $78.71 | Sell | $393,550.00 | |
| Feb. 12, 2019 | Insider | 73,727 | $78.62 | Sell | $5,796,416.74 | |
| Feb. 8, 2019 | Director | 3,052 | $77.22 | Sell | $235,675.44 | |
| Feb. 5, 2019 | Chairman | 231,566 | $78.08 | Sell | $18,080,673.28 | |
| Feb. 4, 2019 | Director | 10,000 | $75.96 | Sell | $759,600.00 | |
| Nov. 8, 2018 | Insider | 225,443 | $75.27 | Sell | $16,969,094.61 | |
| Nov. 7, 2018 | EVP | 36,218 | $75.14 | Sell | $2,721,420.52 | |
| Nov. 1, 2018 | EVP | 277,879 | $73.81 | Sell | $20,510,248.99 | |
| Oct. 31, 2018 | SVP | 47,036 | $74.33 | Sell | $3,496,185.88 | |
| Oct. 30, 2018 | EVP | 25,467 | $72.00 | Sell | $1,833,624.00 | |
| Oct. 2, 2018 | Chairman | 279,850 | $72.07 | Sell | $20,168,789.50 | |
| Oct. 1, 2018 | Major Shareholder | 666,666 | $15.00 | Buy | $9,999,990.00 | |
| Sept. 18, 2018 | Chairman | 279,851 | $70.08 | Sell | $19,611,958.08 | |
| Sept. 17, 2018 | EVP | 107,360 | $70.18 | Sell | $7,534,524.80 | |
| Aug. 3, 2018 | Insider | 29,208 | $65.20 | Sell | $1,904,361.60 | |
| Aug. 2, 2018 | VP | 5,000 | $65.01 | Sell | $325,050.00 | |
| July 31, 2018 | Chairman | 228,091 | $65.00 | Sell | $14,825,915.00 | |
| June 18, 2018 | EVP | 134,094 | $61.00 | Sell | $8,179,734.00 | |
| May 15, 2018 | EVP | 9,972 | $59.66 | Sell | $594,929.52 | |
| April 16, 2018 | Insider | 24,000 | $58.00 | Sell | $1,392,000.00 | |
| Feb. 9, 2018 | Director | 5,000 | $53.57 | Sell | $267,850.00 | |
| Jan. 16, 2018 | Insider | 60,000 | $61.63 | Sell | $3,697,800.00 | |
| Jan. 16, 2018 | EVP | 12,500 | $61.63 | Sell | $770,375.00 | |
| Jan. 12, 2018 | Insider | 5,000 | $58.00 | Sell | $290,000.00 | |
| Nov. 8, 2017 | Director | 5,000 | $56.20 | Sell | $281,000.00 | |
| May 12, 2017 | Director | 5,000 | $63.54 | Sell | $317,700.00 | |
| April 3, 2017 | EVP | 53,850 | $63.48 | Sell | $3,418,398.00 | |
| Feb. 8, 2017 | Director | 5,000 | $64.42 | Sell | $322,100.00 | |
| Feb. 6, 2017 | Director | 5,000 | $64.51 | Sell | $322,550.00 | |
| Feb. 3, 2017 | Director | 5,000 | $63.42 | Sell | $317,100.00 | |
| Feb. 3, 2017 | EVP | 91,959 | $63.96 | Sell | $5,881,697.64 | |
| Nov. 10, 2016 | Chairman | 140,000 | $65.03 | Sell | $9,104,200.00 | |
| Nov. 7, 2016 | EVP | 85,523 | $60.02 | Sell | $5,133,090.46 | |
| Nov. 2, 2016 | Director | 20,000 | $59.06 | Sell | $1,181,200.00 | |
| Oct. 3, 2016 | Insider | 40,800 | $62.07 | Sell | $2,532,456.00 | |
| Sept. 1, 2016 | EVP | 39,200 | $62.61 | Sell | $2,454,312.00 | |
| Aug. 10, 2016 | EVP | 3,000 | $63.03 | Sell | $189,090.00 | |
| Aug. 5, 2016 | Chairman | 392,000 | $61.81 | Sell | $24,229,520.00 | |
| July 5, 2016 | CEO | 60,000 | $58.00 | Sell | $3,480,000.00 | |
| July 5, 2016 | Insider | 45,000 | $57.99 | Sell | $2,609,550.00 | |
| July 1, 2016 | Insider | 30,000 | $57.49 | Sell | $1,724,700.00 | |
| July 1, 2016 | EVP | 50,000 | $57.69 | Sell | $2,884,500.00 | |
| May 20, 2016 | EVP | 39,877 | $54.79 | Sell | $2,184,860.83 | |
| April 14, 2016 | CEO | 131,040 | $56.11 | Sell | $7,352,654.40 | |
| Nov. 4, 2015 | Director | 5,000 | $55.53 | Sell | $277,650.00 |
Insiders are both buying and selling Merck & Company Inc stock.
The insider traders at Merck & Company Inc are: Kenneth C Frazier, Adam H Schechter, Richard R Deluca, Steven Mizell, Sanat Chattopadhyay, Weir Mirian M Graddick, Julie L Gerberding, Wendell P Weeks, Robert M Davis, Rita A Karachun, Frank Clyburn, Clark Golestani, Willie A Deese, Johannes Jacobus Oosthuizen, Bruce N Kuhlik, Willie Deese, Adam Schechter, Adele D Ambrose, Joseph Romanelli, Kenneth Frazier, Merck & Co., Inc., Michael J Holston, Rochelle B Lazarus, Thomas H Glocer, Wendell P. Weeks, Michael J. Holston, Patricia F Russo, Peter C Wendell, Peter C. Wendell, Peter Wendell, John James, John Canan, Rita A. Karachun, C Robert Kidder, Ashley Watson, Roger M Perlmutter, Caroline Litchfield, Bruce Kuhlik, Adele D. Ambrose, Thomas R Cech, Bridgette P Heller, Julie L. Gerberding, Kenneth C. Frazier, Weir Mirian M. Graddick, Leslie A Brun, and Bridgette Heller
The most active insider trader at Merck & Company Inc is Kenneth C Frazier with 26 trades.
Kenneth C Frazier has sold the most Merck & Company Inc stock with a total value of $294,584,131.58.
Merck & Co., Inc. has bought the most Merck & Company Inc stock with a total value of $141,893,846.00.
The most recent insider trade for Merck & Company Inc was on Sept. 4, 2024.
The single biggest insider buy for Merck & Company Inc was from Merck & Co., Inc. with a total value of $65,946,928.00 on April 8, 2019.
The single biggest insider sell for Merck & Company Inc was from Kenneth C Frazier with a total value of $54,610,851.06 on Nov. 9, 2021.